Curtis Sianchuk

Back to Corporate Member News

Karyopharm XPOVIO® New Indication Press Release

1/21/2021

Karyopharm XPOVIO® New Indication Press Release

https://investors.karyopharm.com/2020-12-18-Karyopharm-Announces-FDA-Approval-of-XPOVIO-R-Selinexor-as-a-Treatment-for-Patients-with-Multiple-Myeloma-After-At-Least-One-Prior-Therapy

Powered By GrowthZone